The evolution of insulin therapy: innovations, challenges, and future prospects is reshaping diabetes management, offering improved formulations and delivery systems. Ultra-rapid and ultra-long-acting insulins provide greater flexibility, reducing the risk of hypoglycemia while optimizing glucose control. Smart insulin pens and continuous glucose monitoring integration enhance precision in dosing. However, challenges such as cost, adherence, and weight gain remain significant barriers to widespread adoption. Research is advancing toward glucose-responsive insulins and implantable delivery systems that mimic pancreatic function. As personalized medicine continues to drive innovation, novel insulin analogs and alternative routes of administration, including oral and inhaled formulations, hold promise for the future of diabetes treatment.
Title : Diabetes reduction (pre-diabetes and type 2) with integrative medicine
F Buck Willis, IUHS School of Medicine, Saint Kitts and Nevis
Title : Adipose MTP deficiency protects against hepatic steatosis by upregulating PPAR activity
Sujith Rajan, NYU Long Island School of Medicine, United States
Title : Does winter melon (Benincasa hispida) improves nutritional values and ameliorating glycaemic parameters?
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title : Clinical applications of monitoring unmethylated insulin cfDNA associated with beta-cell death for diabetes and metabolic diseases
Clifford Morris, Kihealth, United States
Title : Diabetes and migration: Impact of internal displacement on the prevalence and management of diabetes in Les Cayes, South Haiti (2022-2024)
Berger Saintius, Field Epidemiology Training Program (FETP), Haiti
Title : Correlation between food insecurity and diabetes in the commune of Les Cayes (2021-2024)
Djeamsly Salomon, Field Epidemiology Training Program (FETP), Haiti